Virtual Teach to Goal vs. Brief Intervention Inhaler Study-outpatient
An RCT of Virtual Teach-to-Goal Versus Brief Instruction for Children With Asthma in Clinics
1 other identifier
interventional
100
1 country
1
Brief Summary
This study aims to evaluate the comparative effectiveness of a high-fidelity, low-resource, and feasible model versus a standardized brief intervention that mimics usual care to deliver tailored inhaler technique education to children with asthma via a randomized clinical trial. We have already conducted a trial of V-TTG among elementary school-aged children hospitalized in the inpatient setting and we now aim to test this tool in the outpatient clinic setting among a broader pediatric patient population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2020
CompletedFirst Posted
Study publicly available on registry
July 14, 2020
CompletedStudy Start
First participant enrolled
August 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 5, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 5, 2021
CompletedFebruary 18, 2022
February 1, 2022
1.3 years
April 16, 2020
February 17, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of participants with effective inhaler use (>75% steps correct) post-intervention with V-TTG versus BI
Inhaler technique will be assessed based on a validated published checklist, which was developed and validated by Dr. Press15 and utilized in my preliminary research with children (see Preliminary Studies). For this primary outcome, we will account for the pre-intervention technique to account for any differences in baseline of the two groups
12 months
Secondary Outcomes (7)
Number of inhaler technique steps correct pre- and post-V-TTG education
At baseline
Number of inhaler technique steps correct at 1 month
1-month after enrollment
Score of Asthma Control Survey
12-months
Score of Asthma Impact
12-months
Score of Caregiver Quality of Life
12-months
- +2 more secondary outcomes
Study Arms (2)
Virtual Teach-to-Goal (V-TTG)
EXPERIMENTALThey will be randomized to receive education via a virtual learning module.
standardized brief intervention
ACTIVE COMPARATORIntervention that mimics usual care to deliver inhaler technique education.
Interventions
Participants will complete inhaler education on a tablet device.
Participants will be read out loud instruction on how to use their inhaler.
Eligibility Criteria
You may qualify if:
- Families will be included in the study if:
- The child is between the ages of 6-17 years old
- The child has a diagnosis of asthma, wheezing, or bronchospasm
- The child has been or is seen in general pediatrics, pediatric pulmonary, or pediatric allergy clinic at the University of Chicago Medical Center
- The child is taking medication for asthma, wheezing, or bronchospasm (either a controller medication or a quick-relief medication)
- The family has acess to wifi and/or data that supports virtual video-based platforms (if study is done virtually)
You may not qualify if:
- Families will be excluded from the study if:
- The child/parent decline or unable to provide consent/assent
- The child/parent does not speak/read English
- The child cannot use an inhaler by themselves without a mask
- The child previously participated in this study
- The family does not have access to wifi and/or data that supports virtual video-based platforms (if study done virtually)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Chicagolead
- American Thoracic Societycollaborator
Study Sites (1)
University of Chicago Medicine
Chicago, Illinois, 60637, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Anna Volerman, MD
University of Chicago
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2020
First Posted
July 14, 2020
Study Start
August 1, 2020
Primary Completion
November 5, 2021
Study Completion
November 5, 2021
Last Updated
February 18, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share